0001387131-16-004517.txt : 20160309 0001387131-16-004517.hdr.sgml : 20160309 20160309131744 ACCESSION NUMBER: 0001387131-16-004517 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160307 FILED AS OF DATE: 20160309 DATE AS OF CHANGE: 20160309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465622433 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 682-8452 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slakter Jason Scott CENTRAL INDEX KEY: 0001630109 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35963 FILM NUMBER: 161493954 MAIL ADDRESS: STREET 1: 57 MEADOW WOODS ROAD CITY: GREAT NECK STATE: NY ZIP: 11020 4 1 slakter-form4_030716.xml OWNERSHIP DOCUMENT X0306 4 2016-03-07 0 0001173281 Ohr Pharmaceutical Inc OHRP 0001630109 Slakter Jason Scott C/O OHR PHARMACEUTICAL INC. 800 THIRD AVE., 11TH FLOOR NEW YORK NY 10022 1 1 0 0 Chief Executive Officer Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 1523 3.70 A 873527 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 327 3.66 A 873854 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 300 3.65 A 874154 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 200 3.64 A 874354 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 2200 3.63 A 876554 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 300 3.61 A 876854 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 400 3.60 A 877254 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 100 3.59 A 877354 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 100 3.58 A 877454 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 100 3.57 A 877554 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 100 3.55 A 877654 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 100 3.50 A 877754 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 100 3.49 A 877854 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 200 3.46 A 878054 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 100 3.44 A 878154 D Common Stock, par value $0.0001 per share 2016-03-07 4 P 0 100 3.41 A 878254 D Common Stock, par value $0.0001 per share 697865 I By SKS Ocular I LLC SKS Ocular I LLC directly owns the shares of Common Stock. On May 30, 2014, the Issuer completed an ophthalmology assets acquisition of SKS Ocular LLC and SKS Ocular I LLC. Pursuant to the acquisition agreement, among other things, SKS Ocular I LLC is eligible to receive additional shares of Common Stock in three contingent milestone payments. Milestone 1 has been met and on December 15, 2015, the Issuer issued 497,859 shares of Common Stock to SKS Ocular I LLC. The Reporting Person has investment and voting power with respect to the Common Stock held by SKS Ocular 1 LLC. Therefore, the Reporting Person may be deemed to beneficially own the shares of Common Stock beneficially owned by SKS Ocular 1 LLC. The Reporting Person disclaims any beneficial ownership of the Common Stock directly owed by SKS Ocular I LLC except to the extent of his pecuniary interest therein. /s/ Jason Scott Slakter 2016-03-09